← All posts

Compounded GLP-1 in New Jersey (2026): Options, Access, and Real Prices

If you live in New Jersey and are looking into compounded GLP-1 medications, the practical questions are usually the same three: is this legal here, how does care actually work, and what does it cost. This page answers all three. It covers how prescribing works under New Jersey’s Telemedicine and Telehealth Act, what the state expects of the pharmacies that ship compounded medication to New Jersey addresses, and what real providers, both national telehealth services and New Jersey clinics, currently charge. Prices in the comparison table come only from each provider’s own public pages, checked on the dates shown in the table.

One disclosure before anything else: this site is operated by Gentle Health, a telehealth provider of compounded semaglutide and tirzepatide. Gentle Health appears in the comparison below on the same terms as every other provider.

How compounded GLP-1 access works in New Jersey

New Jersey law does not require an in-person visit before a physician can prescribe a non-controlled medication like semaglutide or tirzepatide. In fact, the state’s telehealth statute expressly bars licensing boards from imposing an initial in-person visit as a condition of telehealth care, a point covered in detail in the rules section below. What the law does require is a real evaluation by a New Jersey-licensed clinician held to the same standard of care as an office visit. Within that framework, the process at Gentle Health looks like this:

  1. You complete a health intake online. It covers your medical history, current medications, prior experience with GLP-1 therapy, and your goals for weight management.
  2. James Simmons, MD reviews your case. Dr. Simmons is licensed to practice in New Jersey (license 25IA13248400, state board record). New Jersey participates in the Interstate Medical Licensure Compact, an expedited licensing pathway for physicians practicing in multiple states, which the state enacted through P.L.2021, c.332 and which the Board of Medical Examiners administers. Dr. Simmons evaluates whether treatment is appropriate for you, and not everyone qualifies.
  3. If treatment is appropriate, a prescription goes to a licensed compounding pharmacy. The pharmacy prepares the medication and ships it to your New Jersey address, whether that is Newark, Jersey City, Cherry Hill, Toms River, or anywhere in between.
  4. Follow-up continues by telehealth. Dose changes, side effect questions, and check-ins happen with Dr. Simmons, not a rotating cast of unnamed staff.

The plan is cash-pay, with pricing listed publicly further down this page. There is no insurance billing and no membership fee stacked on top of the medication cost.

New Jersey rules worth knowing

New Jersey regulates this category from two directions: rules for the prescriber and rules for the pharmacy. Federal rules sit on top of both.

Telehealth prescribing. New Jersey’s Telemedicine and Telehealth Act, P.L.2017, c.117, sets out the prescriber’s obligations in N.J.S.A. 45:1-62. The essentials:

  • Any provider treating a New Jersey patient by telehealth must be validly licensed in New Jersey, remain subject to the New Jersey licensing board’s oversight, and remain subject to New Jersey jurisdiction. There is no separate “telehealth license”; a standard New Jersey license covers it.
  • Telehealth care, including any prescription issued through it, is held to the same standard of care as an in-person visit. If telehealth cannot meet that standard for a given patient, the statute requires the provider to direct the patient to in-person care.
  • A provider may not issue a prescription based solely on a patient’s answers to a static online questionnaire unless a proper provider-patient relationship has been established. For an initial encounter, the provider must review the patient’s medical history and records before initiating contact. This is a useful screen when you are comparing services: a real evaluation, not just a form, is what New Jersey law expects.
  • The statute directs that board regulations may not require an initial in-person visit as a condition of providing telehealth services. New Jersey’s strictest telehealth prescribing limits apply to Schedule II controlled substances, which generally require an initial in-person examination and periodic in-person follow-up. Semaglutide and tirzepatide are not controlled substances, so those limits do not apply to them.

The pharmacy side. Most compounded GLP-1 prescriptions for New Jersey patients are filled by out-of-state compounding pharmacies, and New Jersey regulates these directly. Under N.J.S.A. 45:14-73 and the Board of Pharmacy’s rule at N.J.A.C. 13:39-4.20, any pharmacy located in another state that ships prescription drugs into New Jersey must register with the New Jersey Board of Pharmacy, renew that registration annually, maintain a valid license in its home state, and staff a toll-free line at least 40 hours a week so New Jersey patients can reach a pharmacist with access to their records. In short, the pharmacy filling your prescription has to answer to the New Jersey Board of Pharmacy, not just its home state’s board. As of this writing (checked July 30, 2026), the New Jersey Board of Pharmacy has not published guidance specific to compounded GLP-1s; the general compounding and out-of-state registration rules above are what govern.

The federal backdrop. The FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025, and has since clarified its policies for compounders as supply stabilized. Large-scale compounding of copies of commercially available products has wound down, and in 2026 the agency has moved to restrict bulk compounding of these ingredients by outsourcing facilities further, as reported by Pharmacy Times. What remains is traditional patient-specific compounding under Section 503A: a licensed prescriber writes a prescription for an individual patient based on that patient’s clinical needs, and a state-licensed pharmacy fills it. That is the pathway legitimate providers, Gentle Health included, operate under. Compounded medications are not FDA-approved, and any provider that glosses over that is not being straight with you.

Compounded semaglutide in New Jersey

Semaglutide is a GLP-1 receptor agonist. It mimics a hormone your body produces after eating, which slows stomach emptying, moderates blood sugar, and reduces appetite. Compounded semaglutide is a patient-specific preparation made with semaglutide by a licensed compounding pharmacy, dispensed in a vial (for injection) or an oral form rather than a manufacturer’s fixed-dose pen. Compounded medications are not FDA-approved, and clinical trial results for brand-name products do not transfer to compounded versions.

For New Jersey patients, Gentle Health offers compounded semaglutide in two forms:

  • Oral semaglutide: starting at $112 per month. No needles. A daily form for people who want to start with the lower-cost option or simply prefer not to inject.
  • Injectable semaglutide: starting at $135 per month. A once-weekly subcutaneous injection, shipped with supplies.

Both prices are cash-pay and dose-tiered. There is no membership fee, published prices for each prescribed dose tier, and no insurance paperwork, because insurance is not billed at all. Whether semaglutide is appropriate for you, and at what dose, is Dr. Simmons’s call after reviewing your health history. Treatment is subject to medical evaluation, and some patients, such as those with a personal or family history of medullary thyroid carcinoma, are not candidates.

Compounded tirzepatide in New Jersey

Tirzepatide works on two receptors rather than one: GLP-1 and GIP, a second gut hormone involved in appetite and metabolism. Compounded tirzepatide, like compounded semaglutide, is prepared by a licensed compounding pharmacy for a specific patient under a physician’s prescription, and it is not FDA-approved.

Gentle Health offers injectable compounded tirzepatide starting at $169 per month, cash-pay, with the same structure as the semaglutide program: evaluation and ongoing care by James Simmons, MD, medication shipped from a compounding pharmacy registered to dispense into New Jersey, and no membership fee layered on top. Tirzepatide is typically the more expensive of the two medications across the market, as the comparison table below shows, so the practical question for many patients is whether to start with semaglutide and reassess. That is a conversation to have during your evaluation rather than a decision to make from a pricing page.

Provider options in New Jersey: comparison table

Methodology: providers listed alphabetically; all prices taken from each provider’s own public pages on the verification date shown in each row; where a price or detail is not published, we write “See site” rather than guessing.

Provider Care model Compounded semaglutide (cash/mo) Compounded tirzepatide (cash/mo) Serves New Jersey Insurance Source
Dr. Medical Health Telehealth; asynchronous physician review $199 (injectable or oral) From $299 Yes (site New Jersey page; states it serves all 50 states) Not required; HSA/FSA accepted drmedhealth.com (verified 2026-07-30)
Garden State Bariatrics & Wellness Center New Jersey clinic program (Millburn); initial visit, follow-ups, medication shipped monthly From $125/week (about $500 per 4 weeks) From $150/week (about $600 per 4 weeks) Yes (Millburn, NJ clinic) Same cash pricing with or without insurance; HSA/FSA accepted Garden State Bariatrics (verified 2026-07-30)
Gentle Health Telehealth; care by James Simmons, MD From $112 (oral) / From $135 (injectable) From $169 (injectable) Yes Cash-pay only; insurance not billed Gentle Health pricing (verified 2026-07-30)
Henry Meds Telehealth; medication plus provider access $247 after intro month (weekly injectable) $349 after intro month (daily oral tablet) See site Not required; cash-pay henrymeds.com (verified 2026-07-30)
OrderlyMeds Telehealth; all-inclusive plans, no membership fee $149 after starter (from $74/mo starter, 2-month program) $299 after starter (from $149/mo starter, 2-month program) Yes (site states licensed professionals in all 50 states) Not required; HSA/FSA accepted orderlymeds.com (verified 2026-07-30)

A few honest notes on reading this table. The care models are genuinely different, not just differently priced. Garden State Bariatrics is a brick-and-mortar New Jersey practice whose program bundles visits and dietitian check-ins, and its prices are quoted weekly, so the 4-week figures above are our arithmetic, not theirs. Henry Meds and OrderlyMeds use introductory pricing that steps up after the first period, so compare the ongoing price, not the starter price. Dr. Medical Health’s tirzepatide price is a “from” figure. Gentle Health’s numbers are dose-tiered monthly prices with no membership fee. None of these structures is objectively right; they suit different people, which is why we list them rather than rank them.

New Jersey FAQ

Is compounded semaglutide legal in New Jersey?

Yes, through the patient-specific pathway. A New Jersey-licensed prescriber writes a prescription for an individual patient, and a compounding pharmacy fills it. Out-of-state pharmacies shipping into New Jersey must be registered with the New Jersey Board of Pharmacy under N.J.S.A. 45:14-73 and N.J.A.C. 13:39-4.20. Compounded medications are not FDA-approved.

Can a doctor really prescribe this in New Jersey without seeing me in person?

Yes. The Telemedicine and Telehealth Act (N.J.S.A. 45:1-62) allows a New Jersey-licensed provider to evaluate and prescribe by telehealth at the same standard of care as an office visit, and it expressly prohibits board rules that would require an initial in-person visit. The statute’s in-person requirements are reserved for Schedule II controlled substances; semaglutide and tirzepatide are not controlled substances.

Is there anything New Jersey law says a telehealth service cannot do?

One rule worth knowing as a consumer: a provider may not prescribe based solely on your answers to a static online questionnaire unless a proper provider-patient relationship exists, and for a first encounter the provider must review your medical history and records. If a service offers a prescription with no clinician review at all, that is not how New Jersey law says it should work.

Who actually provides my care at Gentle Health if I’m in New Jersey?

James Simmons, MD. He is licensed in New Jersey (license 25IA13248400, verifiable through the state licensing lookup). He performs the initial evaluation, writes the prescription if treatment is appropriate, and handles follow-up care and dose adjustments.

Will my insurance or NJ FamilyCare cover compounded GLP-1s?

Generally no. Insurance plans, including NJ FamilyCare, New Jersey’s Medicaid program, rarely cover compounded medications, which is why this market is almost entirely cash-pay. Gentle Health does not bill insurance; the listed figures are starting-tier prices; the dose-tier table below shows the full monthly cost at each prescribed dose. If you have coverage for brand-name GLP-1 therapy through your plan, that is worth exploring with your own physician and insurer, and it is a different product and pathway from anything on this page.

How does the medication get to me in New Jersey?

After Dr. Simmons approves treatment, the prescription goes to a licensed compounding pharmacy registered to dispense into New Jersey, which ships the medication and supplies to your address. Cold-chain packaging is standard for injectable peptides. Shipping timelines vary by pharmacy, typically within about a week of prescription approval. New Jersey’s rules also require registered out-of-state pharmacies to staff a toll-free pharmacist line, so you can call the pharmacy directly with dispensing questions.

I commute to New York or Philadelphia. Does that matter for telehealth?

It can. Telehealth rules generally attach to where the patient is physically located at the time of the visit, and each state licenses separately. If you live in New Jersey, do your visits from New Jersey. If your situation is more complicated, raise it during your evaluation so care is set up correctly.

Why do New Jersey prices range from about $112 to $600 a month for what sounds like the same medication?

Because you are not just buying medication; you are buying a care structure. The higher end of the table (Garden State Bariatrics) is a clinic program with visits and dietitian support bundled in. The middle includes introductory pricing that steps up after the first period. The lower end, including Gentle Health’s $112 oral semaglutide, is telehealth care with medication shipped to you and no bundled extras. Compare what is actually included, not just the headline number.


Current Gentle Health dose tiers and pricing

Gentle Health pricing depends on the dose tier prescribed by your clinician. Current monthly prices are:

Medication Starting Medium High-dose
Oral compounded semaglutide 2–4 mg/day: $112 >4–8 mg/day: $189 >8–12 mg/day: $258
Injectable compounded semaglutide 0.24–0.48 mg/week: $135 >0.48–1.2 mg/week: $179 >1.2–2.4 mg/week: $249
Injectable compounded tirzepatide 2.5–5 mg/week: $169 >5–10 mg/week: $239 >10–15 mg/week: $279

Medication, the initial review by a licensed clinician, video visits and messaging, and overnight refrigerated shipping are included. There is no separate membership fee, and HSA and FSA cards are accepted. Your clinician determines the appropriate medication and dose; the monthly price changes if the prescribed dose moves into a different tier.

Gentle Health currently serves 33 states through clinicians licensed in each state, including New Jersey.

Reviewed by James Simmons, MD

Compounded medications are not FDA-approved. Treatment subject to medical evaluation.